Back to search

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

Data up to Jan 2025

Published1991
Citations373
References38

Total Citations Per Year

Abstract

References (38)

DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS

1989 • 1,799 citations

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

1977 • 1,526 citations

Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide

1987 • 1,175 citations

Risk of Second Cancers after Treatment for Hodgkin's Disease

1988 • 724 citations

Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

1986 • 704 citations

Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia

1989 • 457 citations

Hematologic Neoplasia Associated with Primary Mediastinal Germ-Cell Tumors

1990 • 344 citations

Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia

1990 • 288 citations

Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features.

1986 • 269 citations

The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)

1983 • 267 citations

Acute Nonlymphocytic Leukemia after Therapy with Alkylating Agents for Ovarian Cancer

1982 • 247 citations

Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung

1987 • 233 citations

Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's Disease

1987 • 226 citations

RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASE

1987 • 223 citations

Balanced translocations involving chromosome bands 11q23 and 21q22 are highly characteristic of myelodysplasia and leukemia following therapy with cytostatic agents targeting at DNA-topoisomerase II [letter]

1991 • 210 citations

Risk of Acute Nonlymphocytic Leukemia and Preleukemia in Patients Treated with Cyclophosphamide for Non-Hodgkin's Lymphomas

1985 • 210 citations

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

1988 • 207 citations

Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung

1987 • 204 citations

Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro.

1988 • 168 citations

Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.

1991 • 165 citations

Evidence of a treatment dose response in acute nonlymphocytic leukemias which occur after therapy of non-Hodgkin's lymphoma.

1983 • 156 citations

A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis

1987 • 145 citations

t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy- related myelodysplastic syndrome and acute myeloid leukemia

1990 • 140 citations

t(3;21)(q26;q22): a recurring chromosomal abnormality in therapy- related myelodysplastic syndrome and acute myeloid leukemia

1990 • 128 citations

Leukemic differentiation of a mediastinal germ cell tumor

1989 • 117 citations

Myeloid neoplasia in children treated for solid tumours

1990 • 108 citations

Acute non-lymphocytic leukemia in patients with ovarian carcinoma following long-term treatment with treosulfan (=dihydroxybusulfan)

1980 • 95 citations

Increased incidence of acute nonlymphocytic leukemia following therapy in patients with small cell carcinoma of the lung.

1984 • 80 citations

Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells.

1987 • 75 citations

Acute nonlymphocytic leukemia, preleukemia, and solid tumors following intensive chemotherapy of small cell carcinoma of the lung

1985 • 74 citations

The association of specific “favorable” cytogenetic abnormalities with secondary leukemia

1986 • 74 citations

Sister chromatid exchanges, chromosomal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) Chinese hamster cells.

1988 • 72 citations

Second malignancies in children treated for non-Hodgkin's lymphoma and T-cell leukaemia with the UKCCSG regimens

1987 • 61 citations

Novobiocin enhances alkylating agent cytotoxicity and DNA interstrand crosslinks in a murine model.

1987 • 44 citations

Acute nonlymphocytic leukemia 5 years after treatment with cisplatin, vinblastine, and bleomycin for disseminated testicular cancer

1986 • 39 citations

Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer

1989 • 38 citations

High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer

1990 • 31 citations

Acute leukemia following cisplatin for bladder cancer.

1986 • 17 citations

Cited By (0)

Loading...
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin… (1991) – The Lancet | Metascience Observatory Explorer